高级检索
当前位置: 首页 > 详情页

p16(CDKN2) gene polymorphism: association with histologic subtypes of epithelial ovarian cancer in China

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Departments of Molecular Biology , Hebei Medical University, Fourth Hospital, Shijiazhuang, China [2]Obstetrics and Gynaecology, Hebei Medical University, Fourth Hospital, Shijiazhuang, China
出处:
ISSN:

关键词: epithelial ovarian cancer haplotype p16 single nucleotide polymorphism susceptibility

摘要:
p16 is an important tumor suppressor gene, which is inactivated in many kinds of tumors. The common variants of p16 may be associated with the risk of certain tumors development. We analyzed the frequency of two adjacent polymorphisms in p16 exon 3 (540C -> G and 580C -> T) and their haplotype in blood samples from epithelial ovarian cancer (EOC) patients and healthy controls using polymerase chain reaction-restriction fragment length polymorphism. The results showed that the genotype frequency of p16 580C -> T polymorphism was significantly different among histologic subtypes of EOC (P = 0.02). T allele carriers significantly reduced the risk of serous EOC; the adjusted odds ratio was 0.40 (95% CI = 0.19-0.84). There are neither association between p16 540C -> G polymorphism and EOC development, progression, nor association between the haplotypes of two single nucleotide polymorphisms and the tumor development. Our results suggested that the p16 580C -> T polymorphism might affect the individual susceptibility to specific subtypes of EOC. Different types of ovarian cancer might adopt distinct carcinogenetic pathways. However, this result may be further validated in a larger sample of patients.

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2008]版:
大类 | 4 区 医学
小类 | 3 区 妇产科学 4 区 肿瘤学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 妇产科学 3 区 肿瘤学
JCR分区:
出版当年[2008]版:
Q2 OBSTETRICS & GYNECOLOGY Q3 ONCOLOGY
最新[2023]版:
Q1 OBSTETRICS & GYNECOLOGY Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2008版] 出版当年五年平均 出版前一年[2007版] 出版后一年[2009版]

第一作者:
第一作者机构: [1]Departments of Molecular Biology , Hebei Medical University, Fourth Hospital, Shijiazhuang, China [*1]Hebei Cancer Institute, Hebei Medical University, Fourth Hospital, Jiankanglu 12, Shijiazhuang 050011, China
通讯作者:
通讯机构: [1]Departments of Molecular Biology , Hebei Medical University, Fourth Hospital, Shijiazhuang, China [*1]Hebei Cancer Institute, Hebei Medical University, Fourth Hospital, Jiankanglu 12, Shijiazhuang 050011, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号